HLS Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- HLS Therapeutics's estimated annual revenue is currently $17.9M per year.
- HLS Therapeutics received $125.0M in venture funding in September 2018.
- HLS Therapeutics's estimated revenue per employee is $192,355
- HLS Therapeutics's total funding is $192.2M.
Employee Data
- HLS Therapeutics has 93 Employees.
- HLS Therapeutics grew their employee count by 3% last year.
HLS Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | SVP, Legal, HR and Compliance | Reveal Email/Phone |
4 | VP Scientific Affairs | Reveal Email/Phone |
5 | Associate Director Marketing | Reveal Email/Phone |
6 | Director Finance | Reveal Email/Phone |
7 | Director, Medical Affairs - Cardiovascular | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Senior Director, Human Resources | Reveal Email/Phone |
10 | Brand Manager Neuroscience | Reveal Email/Phone |
HLS Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.5M | 92 | -1% | N/A | N/A |
#2 | $14.3M | 71 | 6% | N/A | N/A |
#3 | $36M | 179 | 8% | N/A | N/A |
#4 | $7.8M | 39 | 8% | N/A | N/A |
#5 | $17.9M | 93 | 3% | $192.2M | N/A |
#6 | $64.9M | 323 | 4% | N/A | N/A |
#7 | $0.5M | 5 | -55% | N/A | N/A |
#8 | $6.8M | 34 | -41% | N/A | N/A |
#9 | $19.5M | 97 | 23% | N/A | N/A |
#10 | $2.5M | 25 | 19% | N/A | N/A |
What Is HLS Therapeutics?
The Heritage of Life Sciences Products HLS Therapeutics is about maintaining the heritage of life science products. We are dedicated to keeping trusted branded drugs on the market. HLS provides access to medications critical to Health Care Providers, patients and their caregivers with the high-quality brand names they trust. Who We Are HLS Therapeutics Inc. is a specialty pharmaceutical company dedicating itself to acquiring and distributing commercial stage mature, or legacy, branded pharmaceutical drugs for the North American markets. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success. Building on the expertise of our founders, HLS is focused on treatment products for the central nervous system, soon to be followed by specialty products in other therapeutic areas. HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), and Philadelphia (Rosemont, Pennsylvania), We source our products from the drug's originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada's regulations. Our Goal/Our Mission HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycle during and post exclusivity, providing access to treatments critical to Health Care Providers, patients and their caregivers with the brand names they trust.
keywords:N/A$192.2M
Total Funding
93
Number of Employees
$17.9M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HLS Therapeutics News
Stifel GMP analyst Justin Keywood remains in a positive headspace about HLS Therapeutics (HLS Therapeutics Stock Quote, Chart, News,...
HLS Therapeutics is not generating a profit, but its free cash flows easily cover the dividend, leaving plenty for reinvestment in the business.
HLS Therapeutics Inc.'s (TSE:HLS) investors are due to receive a payment of CA$0.05 per share on 15th of June.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35M | 101 | 10% | N/A |
#2 | $32.5M | 112 | 8% | N/A |
#3 | $28.4M | 113 | 38% | N/A |
#4 | $23.7M | 113 | 9% | N/A |
#5 | $33.8M | 125 | -5% | N/A |
HLS Therapeutics Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2018-09-13 | $125.0M | Undisclosed | Silicon Valley Bank | Article |